JP2019521189A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019521189A5 JP2019521189A5 JP2019520930A JP2019520930A JP2019521189A5 JP 2019521189 A5 JP2019521189 A5 JP 2019521189A5 JP 2019520930 A JP2019520930 A JP 2019520930A JP 2019520930 A JP2019520930 A JP 2019520930A JP 2019521189 A5 JP2019521189 A5 JP 2019521189A5
- Authority
- JP
- Japan
- Prior art keywords
- carbonyl
- group
- fluoro
- trifluoromethyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662359122P | 2016-07-06 | 2016-07-06 | |
| US62/359,122 | 2016-07-06 | ||
| PCT/US2017/040976 WO2018009717A1 (en) | 2016-07-06 | 2017-07-06 | Trpa1 antagonists for treatment of dry eye, ocular pain and inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019521189A JP2019521189A (ja) | 2019-07-25 |
| JP2019521189A5 true JP2019521189A5 (https=) | 2020-08-20 |
Family
ID=60913192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019520930A Pending JP2019521189A (ja) | 2016-07-06 | 2017-07-06 | ドライアイ、眼痛および炎症の処置のためのｔｒｐａ１アンタゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200179357A1 (https=) |
| EP (1) | EP3481808A4 (https=) |
| JP (1) | JP2019521189A (https=) |
| CA (1) | CA3029901A1 (https=) |
| IL (1) | IL264069A (https=) |
| SG (1) | SG11201811655SA (https=) |
| WO (1) | WO2018009717A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015103060A1 (en) | 2014-01-06 | 2015-07-09 | Algomedix, Inc. | Trpa1 modulators |
| TW202100144A (zh) * | 2019-03-08 | 2021-01-01 | 日商樂敦製藥股份有限公司 | 刺激感經抑制之眼科組合物 |
| US12178797B2 (en) | 2019-05-03 | 2024-12-31 | Zyus Life Sciences Inc. | Formulation for pain management |
| US12220396B2 (en) | 2019-05-03 | 2025-02-11 | Zyus Life Sciences Inc. | Formulation for pain management |
| WO2020223800A1 (en) * | 2019-05-03 | 2020-11-12 | Zyus Life Sciences Inc. | Formulation for pain management |
| GR1010012B (el) * | 2020-05-12 | 2021-05-27 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον κυκλοσπορινη |
| IT202100015098A1 (it) | 2021-06-09 | 2022-12-09 | Flonext S R L | Composto antagonista del canale trpa1 per uso in patologie degenerative della retina |
| GB2625649A (en) * | 2021-07-12 | 2024-06-26 | Ocusoft Inc | Skin moisturizing compositions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999058523A1 (en) * | 1998-05-14 | 1999-11-18 | G.D. Searle & Co. | 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| EP1620095A4 (en) * | 2003-04-24 | 2009-04-01 | Merck & Co Inc | HEMMER OF ACT ACTIVITY |
| WO2015103060A1 (en) * | 2014-01-06 | 2015-07-09 | Algomedix, Inc. | Trpa1 modulators |
-
2017
- 2017-07-06 JP JP2019520930A patent/JP2019521189A/ja active Pending
- 2017-07-06 WO PCT/US2017/040976 patent/WO2018009717A1/en not_active Ceased
- 2017-07-06 US US16/315,113 patent/US20200179357A1/en not_active Abandoned
- 2017-07-06 SG SG11201811655SA patent/SG11201811655SA/en unknown
- 2017-07-06 CA CA3029901A patent/CA3029901A1/en not_active Abandoned
- 2017-07-06 EP EP17824925.6A patent/EP3481808A4/en not_active Ceased
-
2019
- 2019-01-03 IL IL264069A patent/IL264069A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019521189A5 (https=) | ||
| TWI643622B (zh) | 用於治療乾眼症及其他眼部相關疾病之ｊａｎｕｓ激酶抑制劑 | |
| CN101980708B (zh) | 作为vegf驱动的血管生成过程的有效调节剂的咪唑并喹啉类及嘧啶衍生物 | |
| JP2019521189A (ja) | ドライアイ、眼痛および炎症の処置のためのｔｒｐａ１アンタゴニスト | |
| JP6185574B2 (ja) | 耳鳴りを治療するためのｈ４受容体阻害剤 | |
| TWI655946B (zh) | 自體免疫疾病之治療 | |
| JP2021178842A (ja) | 自己免疫疾患の処置 | |
| CA2582324A1 (en) | Compositions and methods for treating ophthalmic diseases | |
| JP7007559B2 (ja) | 白内障の予防剤および治療剤、並びに、これらを製造するための、ｄｎａ損傷に応答するシグナル伝達経路を阻害する阻害剤の使用 | |
| JP2016521706A (ja) | １ｈ−インドール−１−カルボキサミド誘導体を含有する局所水性眼科用組成物および眼疾患の治療へのその使用 | |
| JP2016521706A5 (https=) | ||
| AU2017342240A1 (en) | Methods for treating ocular disease using inhibitors of CSF-1R | |
| JP2019534269A5 (https=) | ||
| US8729056B2 (en) | Preventive and/or therapeutic agent of hand-foot syndrome | |
| AU2023383105A1 (en) | Enhancement of the efficacy of serotonergic psychedelic drugs in the treatment or prevention of certain neuropsychiatric disorders through inhibition of type-9 phosphodiesterases | |
| WO2023034467A2 (en) | Cgrp antagonists for treating skin conditions | |
| JP4681734B2 (ja) | ピリドンカルボン酸の可溶化方法、その可溶化剤、ピリドンカルボン酸含有水溶液剤およびその製造方法 | |
| WO2026000074A1 (en) | Use of cd38 inhibitors for reducing th2 inflammation | |
| AU2004237153A1 (en) | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal | |
| AU2012203914C1 (en) | 5imidazoquinolines and pyrimidine derivatives as potent modulators of VEGF-driven angiogenic processes | |
| CA2203379C (en) | Cgmp-pde inhibitors for the treatment of erectile dysfunction |